ConductScience.org, home

Paper42873441PubMed

Current Evidence on the Use of Calcitonin Gene-Related Peptide-Targeting Therapies in Children and Adolescents.

Shin L and 2 others. Curr Pain Headache Rep, 2026.

Cite this record

ConductScience Library. Current Evidence on the Use of Calcitonin Gene-Related Peptide-Targeting Therapies in Children and Adolescents. Papers, record 42873441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42873441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current Evidence on the Use of Calcitonin Gene-Related Peptide-Targeting Therapies in Children and Adolescents.
Journal
Curr Pain Headache Rep
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-17

Source PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shin LLauren
2Moon RRyan
3Gelfand AAmy

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcitonin Gene-Related PeptideMajor topic
Migraine DisordersMajor topic
Humans
Child
Adolescent
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal

Source PubMed

Download CSV of topics

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136788886Monoclonal Antibodies Against the Calcitonin Gene-Related Peptide and Its Receptor in Japanese Adolescents With Migraines.Cureus2023https://conductscience.org/library/papers/36788886PubMed
231800988Ubrogepant for the Treatment of Migraine.N Engl J Med2019https://conductscience.org/library/papers/31800988PubMed
330733702Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine.Front Neurol2019https://conductscience.org/library/papers/30733702PubMed
431291515Trial of Galcanezumab in Prevention of Episodic Cluster Headache.N Engl J Med2019https://conductscience.org/library/papers/31291515PubMed
536587297Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache.Cephalalgia2023https://conductscience.org/library/papers/36587297PubMed
635690723European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.J Headache Pain2022https://conductscience.org/library/papers/35690723PubMed
715836598The placebo responder rate in children and adolescents.Headache2005https://conductscience.org/library/papers/15836598PubMed
81699472Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.Ann Neurol1990https://conductscience.org/library/papers/1699472PubMed
98388188The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.Ann Neurol1993https://conductscience.org/library/papers/8388188PubMed
1036633118Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review.Headache2023https://conductscience.org/library/papers/36633118PubMed
1131550910CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.Cephalalgia2019https://conductscience.org/library/papers/31550910PubMed
1223109652Migraine and migraine subtypes in preadolescent children: association with school performance.Neurology2012https://conductscience.org/library/papers/23109652PubMed
137518321Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.Brain1994https://conductscience.org/library/papers/7518321PubMed
1432003253Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.Expert Opin Ther Targets2020https://conductscience.org/library/papers/32003253PubMed
1541235617Gepants for headache prevention in children and adolescents: A multicenter chart review study.Headache2026https://conductscience.org/library/papers/41235617PubMed
1629171821A Controlled Trial of Erenumab for Episodic Migraine.N Engl J Med2017https://conductscience.org/library/papers/29171821PubMed
1737979595Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.Lancet2023https://conductscience.org/library/papers/37979595PubMed
1829848108Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.Cephalalgia2018https://conductscience.org/library/papers/29848108PubMed
1928176234Frequent mild head injury promotes trigeminal sensitivity concomitant with microglial proliferation, astrocytosis, and increased neuropeptide levels in the trigeminal pain system.J Headache Pain2017https://conductscience.org/library/papers/28176234PubMed
2041534042Fremanezumab in Children and Adolescents with Episodic Migraine.N Engl J Med2026https://conductscience.org/library/papers/41534042PubMed

See all 73 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42873441

GET https://conductscience.org/api/papers/v1/42873441/references?page=2